Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease,
affecting approximately 30% of Western populations and a frequent indication for liver …

With the increasing number of individuals with diabetes and obesity, nonalcoholic fatty liver
disease (NAFLD) is becoming increasingly prevalent, affecting one-quarter of adults …

OBJECTIVE. The purpose of this study is to explore the diagnostic performance of two
investigational quantitative ultrasound (QUS) parameters, attenuation coefficient and …

Purpose To assess diagnostic performance of quantitative ultrasound (QUS) biomarkers in
assessing hepatic steatosis. Methods We prospectively recruited 125 participants (mean …

Nonalcoholic fatty liver disease (NAFLD) is an emerging epidemic worldwide and is
regarded as a hepatic manifestation of metabolic syndrome (MetS). Only a few studies have …

Noninvasive diagnoses of nonalcoholic fatty-liver disease (NAFLD) involve the use of
serologic markers and imaging methods, such as conventional ultrasonography (US) …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in Western countries. Although no specific studies have been performed, the estimated …

Diagnostic performance of a novel ultrasound-based quantitative method to assess liver
steatosis in histologically identified no Page 1 Med Ultrason 2023, Vol. 25, no. 1, 7-13 DOI …

Abstract Background/Aims Nonalcoholic fatty liver disease (NAFLD) is the most common
liver disease worldwide. Ultrasound, the most used tool for diagnosing NAFLD, is operator …